Cardiovascular Risk Evaluation in Psoriatic Arthritis by Aortic Stiffness and the Systemic Coronary Risk Evaluation (SCORE): Results of the Prospective PSOCARD Cohort Study.
Konstantinos TriantafylliasStefanie LiverakosMuthuraman MuthuramanLorenzo CavagnaIoannis ParodisAndreas SchwartingPublished in: Rheumatology and therapy (2024)
In the largest cfPWV/PsA cohort examined to date, patients with PsA exhibited increased aortic stiffness compared to healthy controls. PsA duration was the most important independent disease-associated predictor of increased aortic stiffness, next to traditional CV risk factors. cfPWV measurements may help identify subclinical end-organ disease and abnormal aortic stiffness and thus assist CV risk classification in PsA.
Keyphrases
- prostate cancer
- aortic valve
- pulmonary artery
- radical prostatectomy
- left ventricular
- risk factors
- aortic dissection
- coronary artery
- coronary artery disease
- aortic stenosis
- transcatheter aortic valve replacement
- machine learning
- deep learning
- pulmonary hypertension
- pulmonary arterial hypertension
- atrial fibrillation
- drug induced